Mondal, Arindam
Roberge, Jacques
Gilleran, John
Peng, Youyi
Jia, Dongxuan
Akel, Moumen
Patel, Yash
Zoltowski, Harrison
Doraiswamy, Anupama
Langenfeld, John
Funding for this research was provided by:
Office of Extramural Research, National Institutes of Health (CA225830)
Rutgers, The State University of New Jersey (U01HL150852)
Article History
Received: 29 March 2022
Accepted: 18 May 2022
First Online: 27 June 2022
Declarations
:
: No approval and consent to participate was required.
: All authors have agreed to publish this manuscript.
: A provisionary patent has been filed for developing BMP small molecule inhibitors, which does not include JL5. There are no active or pending financial agreements regarding these compounds.